Lilly launches Mounjaro in India for treatment of obesity and type 2 diabetes
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Experts urge early detection & better access to care
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
No safety signals related to the vaccine candidate were identified
Subscribe To Our Newsletter & Stay Updated